Optimizing the Choice for Adjuvant Chemotherapy in Gastric Cancer

Optimizing the Choice for Adjuvant Chemotherapy in Gastric Cancer

Advances in the management of gastric cancer have improved patient survival in the last decade. Nonetheless, the number of patients relapsing and dying after a diagnosis of localized gastric cancer is still too high, even in early stages (10% in stage I). Adjuvant systemic chemotherapy has been prov...

Full description

Bibliographic Details
Main Authors: Antonino Grassadonia, Antonella De Luca, Erminia Carletti, Patrizia Vici, Francesca Sofia Di Lisa, Lorena Filomeno, Giuseppe Cicero, Laura De Lellis, Serena Veschi, Rosalba Florio, Davide Brocco, Saverio Alberti, Alessandro Cama, Nicola Tinari
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cancers
Subjects:
gastric cancer
adjuvant chemotherapy
predictive factors
prognostic factors
Online Access:https://www.mdpi.com/2072-6694/14/19/4670

Internet

https://www.mdpi.com/2072-6694/14/19/4670

Similar Items